Melanotan 2 (MT2)
On 2nd Jan this year (2023), we received a notice from the MHRA (the body that regulates medicines in the UK), requiring us to stop listing/selling Melanotan 2 (MT2). In their view, this peptide had physiological effects and thus comes under their remit as a medicine - and we do not have a licence to sell it. The remit that the MHRA has is defined in British law and it effectively allows the MHRA to regulate any compound that it deems to be a medicine - essentially, they are both judge and jury and there’s no avenue to appeal. While frustrating, it does perhaps indicate that although Melanotan 2 has never completed clinical trials, in their eyes it is an effective compound in facilitating tanning!
The MHRA appear to be having a crack-down on MT2 as far as we can tell and they have history of doing this in the past. But in doing so, they deprive people access to what, in our humble opinion, is a very useful and effective peptide. Please feel free to email us at [email protected] for any updates.